David Ledbetter is chief clinical officer of Dascena, a personalized medicine company.
David Ledbetter
Chief clinical officer
Dascena
From this contributor
There are no autism-specific genes, just brain genes
There is not yet a single example of a gene that, when mutated, increases the likelihood of autism but not of other neurodevelopmental conditions, including intellectual disability.
There are no autism-specific genes, just brain genes
By
David Ledbetter, Scott Myers
23 March 2021 | 5 min read
Developmental disorders should be viewed as continuum
Intellectual disability, autism, epilepsy and schizophrenia should be considered part of a spectrum of developmental brain dysfunction, says David Ledbetter.
Developmental disorders should be viewed as continuum
By
David Ledbetter
6 May 2013 | 5 min read
Explore more from The Transmitter
Understanding fragile X syndrome
Just in time for Fragile X Awareness Month, The Transmitter rounds up notable coverage.
Understanding fragile X syndrome
Just in time for Fragile X Awareness Month, The Transmitter rounds up notable coverage.
By
Daisy Yuhas
4 July 2024 | 2 min read
Future of BRAIN Initiative funding remains unclear
As the U.S. Congress begins to discuss federal science funding for 2025, any plans to compensate for this year’s cuts to the neuroscience program face an uphill battle.
Future of BRAIN Initiative funding remains unclear
As the U.S. Congress begins to discuss federal science funding for 2025, any plans to compensate for this year’s cuts to the neuroscience program face an uphill battle.
By
Angie Voyles Askham
3 July 2024 | 4 min read
Computational and systems neuroscience needs development
Embracing recent advances in developmental biology can drive a new wave of innovation.
Computational and systems neuroscience needs development
Embracing recent advances in developmental biology can drive a new wave of innovation.
By
Ben Scott
2 July 2024 | 6 min read